Disease modification upon 2 weeks of tofacitinib treatment in a mouse model of chronic epilepsy
{{output}}
All current drug treatments for epilepsy, a neurological disorder affecting more than 50 million people, merely treat symptoms, and a third of patients with epilepsy do not respond to medication. There are no disease-modifying treatments that may be administer... ...